A0A6D2WE91 (A0A6D2WE91_PANTR) Pan troglodytes (Chimpanzee)
CTSL isoform 3 UniProtKBInterProInteractive Modelling
333 aa; Sequence (Fasta) ;
3 identical sequences: Homo sapiens: P07711; Pan troglodytes: H2QXF0; Pan paniscus: A0A2R9ACG6
It is possible new templates exist for this target since these models were created.
Available Structures
64 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of cysteine protease inhibitor, chagasin, in complex with human cathepsin L |
Heteromer P07711; Q966X9; | 99.55 | 1×NAG; 1×NA; 1×CL; | |||
| Unreduced cathepsin L in complex with stefin A |
Heteromer P01040; P07711; | 99.09 | ||||
| CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L |
Heteromer P04233; P07711; | 100 | 1×NAG; | |||
| Cathsilicatein, a chimera | homo-4-mer | 92.53 | 8×SO4; | |||
| Crystal structure of human cathepsin L in complex with the vinyl sulfone inhibitor K777 | homo-4-mer | 99.55 | 4×D1R; 1×PG4; 12×EDO; 5×PEG; 6×DMS; 3×PGE; | |||
| Crystal structure of human cathepsin L after reaction with the bound ketoamide inhibitor 13b | homo-4-mer | 99.55 | 4×KH0; 11×DMS; 8×PEG; 1×PG4; 10×EDO; 3×PGE; | |||
| Caught in the Act: The Crystal Structure of cleaved Cathepsin L bound to the active site of Catheps… | homo-2-mer | 99.06 | 4×SO4; 2×GOL; | |||
| CATHEPSIN L IN COMPLEX WITH AC1115 | homo-2-mer | 100.0 | 2×W28; | |||
| Design of non-covalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized … | homo-2-mer | 100 | ||||
| HUMAN CATHEPSIN L APO FORM WITH ZN | homo-2-mer | 100 | 2×ZN; 2×GOL; 2×ACT; | |||
| Crystal structure of mature apo-Cathepsin L C25A mutant | homo-2-mer | 99.54 | 1×NAG; 5×GOL; 4×SO4; 1×NA; | |||
| CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-17-oxa-4-azatricyclo[16… | homo-2-mer | 100.0 | 2×C7Q; | |||
| Structure of a proline specific mutant of human cathepsin L | monomer | 98.4 | 1×GOL; 12×EOH; 1×PEG; 1×EDO; 1×PGE; | |||
| CRYSTAL STRUCTURE OF PROCATHEPSIN L | monomer | 99.37 | ||||
| Structure of mutant human cathepsin L, engineered for GAG binding | monomer | 97.45 | 14×GOL; 3×CL; 5×NA; 8×PO4; 10×POL; 6×PGE; 3×EOH; 2×EDO; | |||
| CRYSTAL STRUCTURE OF A CYSTEINE PROTEASE PROFORM | monomer | 98.7 | ||||
| Structural Basis for Irreversible Inhibition of Human Cathepsin L by a Diazomethylketone Inhibitor | monomer | 100 | 1×I0X; | |||
| Structural Basis for Reversible and Irreversible Inhibition of Human Cathepsin L by their Respectiv… | monomer | 100 | 1×I0Y; | |||
| CATHEPSIN L WITH A NITRILE INHIBITOR | monomer | 100 | 1×XU3; 2×BTB; 1×CL; | |||
| CATHEPSIN L IN COMPLEX WITH (2S,4R)-4-(2-Chloro-4-methoxy-benzenesulfonyl)-1-[3-(5-chloro-pyridin-2… | monomer | 100.0 | 1×7KN; 4×EDO; | |||
| CATHEPSIN L IN COMPLEX WITH 4-[cyclopentyl(imidazo[1,2-a]pyridin-2-ylmethyl)amino]-6-morpholino-1,3… | monomer | 100.0 | 1×7KH; 1×EDO; | |||
| CATHEPSIN L WITH A NITRILE INHIBITOR | monomer | 100.0 | 1×DJT; 2×GOL; | |||
| CATHEPSIN L IN COMPLEX WITH 4-[1,3-benzodioxol-5-ylmethyl(2-phenoxyethyl)amino]-5-fluoropyrimidine-… | monomer | 100.0 | 1×GH4; 8×EDO; | |||
| CATHEPSIN L WITH A NITRILE INHIBITOR | monomer | 100.0 | 1×424; | |||
| CATHEPSIN L WITH A NITRILE INHIBITOR | monomer | 100.0 | 1×YJ2; 1×GOL; | |||
| Crystal structure of cathepsin L in complex with AZ12878478 | monomer | 99.55 | 1×NOW; 1×PG4; 1×ACT; | |||
| CATHEPSIN L WITH A NITRILE INHIBITOR | monomer | 100.0 | 1×YJ8; 1×GOL; | |||
| Crystal structure of human Cathepsin L in complex with covalently bound Calpeptin | monomer | 99.55 | 2×PEG; 2×PGE; 1×EDO; 1×RN2; | |||
| CATHEPSIN L WITH A NITRILE INHIBITOR | monomer | 100.0 | 1×YJ9; 1×GOL; | |||
| CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4-azatricyc… | monomer | 100.0 | 1×C3E; 2×GOL; | |||
| CATHEPSIN L WITH A NITRILE INHIBITOR | monomer | 100 | 1×YJ9; 1×GOL; | |||
| Crystal structure of human cathepsin L with covalently bound Cathepsin L inhibitor IV | monomer | 99.55 | 1×L2F; 1×PEG; 1×EDO; 2×DMS; | |||
| CATHEPSIN L IN COMPLEX WITH (2S,4R)-4-(2-Chloro-4-methoxy-benzenesulfonyl)-1-[3-(5-chloro-pyridin-2… | monomer | 100.0 | 1×GOL; 1×5T9; | |||
| CATHEPSIN L WITH A NITRILE INHIBITOR | monomer | 99.53 | 1×424; | |||
| Crystal structure of human Cathepsin L in complex with covalently bound MG132 | monomer | 99.55 | 1×ALD; 2×PEG; | |||
| Crystal structure of human cathepsin L with covalently bound calpain inhibitor VI | monomer | 99.55 | 1×JQO; 2×DMS; | |||
| Crystal structure of human cathepsin L with covalently bound aloxistatin (E-64D) | monomer | 99.55 | 1×E6D; 1×1PE; 1×PG4; 1×DMS; 1×PEG; 2×PGE; 1×EDO; | |||
| Crystal structure of human cathepsin L in complex with covalently bound CLIK148 | monomer | 99.55 | 1×KXL; 1×PG4; 1×1PE; 2×DMS; 3×PEG; | |||
| CATHEPSIN L WITH A NITRILE INHIBITOR | monomer | 100.0 | 1×XU5; 1×GOL; 1×FLC; | |||
| Crystal structure of apo human Cathepsin L | monomer | 99.55 | 3×PEG; 1×PGE; 1×EDO; | |||
| Crystal structure of human cathepsin L with covalently bound E-64 | monomer | 99.55 | 1×E64; 2×PEG; | |||
| Crystal structure of human Cathepsin L after incubation with Sulfo-Calpeptin | monomer | 99.55 | 2×PEG; 1×RN2; | |||
| Human cathepsin L after reaction with the thiocarbazate inhibitor CID 16725315 | monomer | 99.55 | 1×TXH; 4×EDO; 1×PG4; | |||
| Crystal structure of human cathepsin L in complex with calpain inhibitor XII | monomer | 99.55 | 2×PGE; 1×M6L; 1×DMS; | |||
| Crystal structure of human Cathepsin L with covalently bound Calpain inhibitor III | monomer | 99.55 | 1×L3F; 1×PEG; 1×PGE; 1×PG4; | |||
| Crystal structure of human Cathepsin L in complex with covalently bound GC376 | monomer | 99.55 | 2×PEG; 1×NA; 1×PGE; 1×CL; 1×UED; | |||
| A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors(co… | monomer | 100.0 | 1×NSY; | |||
| Crystal structure of human cathepsin L in complex with covalently bound MG-101 | monomer | 99.55 | 1×PGE; 1×NA; | |||
| Human cathepsin L in complex with covalently bound CA-074 methyl ester | monomer | 99.55 | 1×WRH; 1×PEG; 2×EDO; | |||
| Crystal structure of human cathepsin L interacting with tosyl phenylalanyl chloromethyl ketone (TPC… | monomer | 99.55 | 1×TQ8; 1×EDO; 2×PEG; 3×DMS; 1×PGE; 1×PG5; 1×VLF; | |||
| Crystal structure of human cathepsin L with CAA0225 | monomer | 99.55 | 1×L2X; 2×NA; 5×PEG; | |||
| Crystal structure of human cathepsin L forming a thiohemiacetal with N-Boc-2-aminoacetaldehyde | monomer | 99.55 | 1×OYU; 1×PGE; 1×DMS; 2×EDO; 1×PEG; 2×NA; | |||
| The crystal structure of human CtsL in complex with 14c | monomer | 100 | 2×DMS; 1×KJ0; | |||
| Crystal structure of CTSL in complex with E64d | monomer | 100.0 | 1×E6D; | |||
| CATHEPSIN L IN COMPLEX WITH (3S,14E)-8-(azetidin-3-yl)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17… | monomer | 100 | 1×C7T; 6×ZN; 1×CL; | |||
| Crystal structure of CTSL in complex with K777 | monomer | 100 | 7×ZN; 2×CAC; 1×0IW; | |||
| Exploring inhibitor binding at the S subsites of cathepsin L | monomer | 100.0 | 1×OPT; | |||
| CATHEPSIN L with AZ13010160 | monomer | 99.53 | 1×BD3; | |||
| The crystal structure of human CtsL in complex with 14a | monomer | 100 | 1×89B; | |||
| A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors(co… | monomer | 100.0 | 1×NSX; | |||
| A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors (c… | monomer | 100.0 | 1×NSZ; | |||
| Crystal structure of mature apo-Cathepsin L C25A mutant in complex with Gln-Leu-Ala peptide | monomer | 99.55 | 1×NAG; | |||
| TRIAZINE CATHEPSIN INHIBITOR COMPLEX | monomer | 100.0 | 1×GOL; 1×V65; | |||
| The crystal structure of human CtsL in complex with 14b | monomer | 100 | 1×89K; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6jd8.1.A | monomer | 0.87 | 98.42 | |||